The Role of Antiandrogens in the Treatment of Sex Offenders

  • Paul A. Walker
Part of the Perspectives in Sexuality book series (Persp. Sex.)


The purpose of this chapter is to present data and discussion pertaining to the use of an antiandrogenic hormone, in combination with psychologic counseling, in the treatment of sex offenders.


Sexual Arousal Sexual Offense Psychologic Counseling Medroxyprogesterone Acetate Cyproterone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bancroft, J. A comparative study of aversion and desensitization in the treatment of homosexuality. In L. Burns & J. Worsley (Eds.), Behaviour therapy in the 1970’s. Bristol, England: Wright, 1970.Google Scholar
  2. Bancroft, J. The behavioral approach to sexual disorders. In H. Milne & S. Hardy (Eds.), Psycho-sexual problems. Baltimore: University Park Press, 1975.Google Scholar
  3. Barlow, D. Increasing heterosexual responsiveness in the treatment of sexual deviation: A review of the clinical and experimental evidence. Behavior Therapy, 1973, 4, 655–671.CrossRefGoogle Scholar
  4. Freund, K. Diagnosis and treatment of forensically significant anomalous erotic preferences. Canadian Journal of Criminology and Corrections, 1976, 18, 181–189.Google Scholar
  5. Frisbie, L. V., & Dondis, E. H. Recidivism among treated sex offenders. Research Monograph No. 5. Department of Mental Hygiene, State of California, 1965.Google Scholar
  6. Humphreys, L. Tearoom trade. Chicago: Aldine, 1970.Google Scholar
  7. Laschet, U., & Laschet, L. Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 1975, 6, 821–826.CrossRefGoogle Scholar
  8. Meyer, W. J., Walker, P. A., Wiedeking, C., Money, J., Kowarski, A., Migeon, C., & Borgaonkar, D. Pituitary function in adult males receiving medroxyprogesterone acetate. Fertility and Sterility, 1977, 28, 1072–1076.Google Scholar
  9. Money, J. Discussion on hormonal inhibition of libido in male sex offenders. In R. P. Michael (Ed.), Endocrinology and human behavior. London: Oxford University Press, 1968.Google Scholar
  10. Money, J. Use of an androgen-depleting hormone in the treatment of male sex offenders. The Journal of Sex Research, 1970, 6(3), 165–172.CrossRefGoogle Scholar
  11. Money, J., & Ehrhardt, A. Man and woman; boy and girl: The differentiation and dimorphism of gender identity from conception to maturity. Baltimore: Johns Hopkins University Press, 1972.Google Scholar
  12. Money, J., Wiedeking, C., Walker, P. A., & Gain, D. Combined antiandrogenic and counseling program for treatment of 46, XY and 47, XYY sex offenders. In E. Sacher (Ed.), Hormones, behavior and psychopathology. New York: Raven Press, 1976.Google Scholar
  13. Money, J., Wiedeking, C., Walker, P. A., Migeon, C., Meyer, W., & Borgaon-kar, D. 47, XYY and 46, XY males with antisocial and/or sex offending behavior: Antiandrogen plus counseling. Psychoneuroendocrinology, 1975, 1, 165–178.CrossRefGoogle Scholar
  14. Shorkey, C., & Cangelosi, S. Modification of sexual behavior: Summary and annotated bibliography. Washington, D.C.: American Psychological Association (JSAS Document MS 1114), 1975.Google Scholar
  15. Walker, P. A. Medroxyprogesterone acetate as an antiandrogen for the rehabilitation of sex offenders. In R. Gemme & C. Wheeler (Eds.), Progress in sexology, selected proceedings of the 1976 international congress of sexology. New York: Plenum Press, 1977.Google Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • Paul A. Walker
    • 1
  1. 1.The Johns Hopkins University School of MedicineThe University of BaltimoreBaltimoreUSA

Personalised recommendations